Introduction of imatinib as first-line therapy for chronic myeloid leukemia in Cuba.

Autor: Morán VP; Hematology and Immunology Institute, Havana, Cuba. valia.pavon@infomed.sld.cu, Baute RG, Facundo JC, Ramírez PH, Núñez AA, Martínez EE, Cabrera OM, Padrón CH, Otero AG, Uría JC, Estrada EE, Díaz RM, Virgil AM, Sánchez KL, Cabeza AH

Publikováno v: MEDICC review [MEDICC Rev] 2011 Jan; Vol. 13 (1), pp. 35-40.